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ABSTRACT 
Objective 
Despite surgical advances, childhood tracheal stenosis is associated with high 
morbidity and mortality. Various tracheal scaffold strategies have been 
developed as the basis for bioengineered substitutes, but there is no 
consensus on which may be superior in vivo. We hypothesized that there 
would be no difference in morbidity and mortality between three competing 
scaffold strategies in rabbits. 
 
Study Design 
Pilot pre-clinical study.  
 
Methods 
Tracheal scaffolds were prepared by three methods that have been applied 
clinically and reported: preserved cadaveric (“Herberhold”) allografts, 
detergent-enzymatically decellularized allografts and synthetic scaffolds 
(nanocomposite polymer POSS-PCU). Scaffolds were implanted into cervical 
trachea of New Zealand White rabbits (n=4 per group) without cell seeding. 
Control animals (n=4) received autotransplanted tracheal segments using the 
same technique. Animals underwent bronchoscopic monitoring of the grafts 
for 30 days. Macroscopic evaluation of tissue integration, graft stenosis and 
collapsibility and histological examinations were performed on explants at 
termination. 
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Results 
All surgical controls survived to termination without airway compromise. Mild 
to moderate anastomotic stenosis from granulation tissue was detected, but 
there was evidence suggestive of vascular reconnection with minimal fibrous 
encapsulation. In contrast, three of the four animals in Herberhold and POSS-
PCU groups, and all animals receiving decellularized allografts, required early 
termination due to respiratory distress. Herberhold grafts showed intense 
inflammatory reactions, anastomotic stenoses and mucus plugging. Synthetic 
graft integration and vascularization was poor, whilst decellularized grafts 
demonstrated malacia and collapse but had features suggestive of vascular 
connection or revascularization.  
 
Conclusion 
There are mirror-image benefits and drawbacks to non-recellularized, 
decellularized and synthetic grafts, such that neither emerged as the preferred 
option. Results from pre-vascularized and/or cell-seeded grafts (as applied 
clinically) may elucidate clearer advantages of one scaffold type over another. 
 
KEYWORDS 
Tissue Engineering, Tracheal Transplantation, Tracheal Stenosis, Paediatric 
Airway 
 
LEVEL OF EVIDENCE 
N/A 
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INTRODUCTION 
Tracheal stenosis in children can be problematic to treat, particularly long-
segment disease where surgical resection is not an option. The increasing 
use of slide tracheoplasty has transformed the outcomes for children with 
long-segment congenital tracheal stenosis1 but those born with severe 
congenital malformations of the airway (e.g. type IV laryngeal clefts) or those 
with extensive large airway disease are often considered untreatable2. In such 
circumstances tracheal replacement is a possible approach3.  
 
Allotransplantation has been proposed, but a shortage of donors and the 
morbidity associated with lifelong post-transplant immunosuppression4 are 
significant hurdles to routine clinical use5-7. Cadaveric tracheae (homografts) 
rendered less immunogenic by chemical processing have been used with 
patch augmentation and preservation of the existing posterior wall, but clinical 
outcomes have been mixed and their long-term function is unpredictable. 
Decellularization of allograft tracheae, where cells (and their epitopes) are 
removed by mechanical/chemical processing, creates a hypothetically 
functional and non-allogeneic scaffold8-11. Synthetic scaffolds created from 
novel polymers have also been applied clinically, though the exact material to 
use in this context remains undecided and outcomes are unclear12.  
 
This pilot study directly compares three tracheal replacement strategies using 
different scaffolds. We hypothesized that there would be no difference in 
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morbidity and mortality of rabbits implanted with such tracheal replacements. 
Scaffolds were not engrafted with cells in this pilot study in order to simplify 
the comparison of scaffold materials in the absence of other variables such as 
the influence of seeded cells or growth factors, and to gather data about the in 
vivo efficacy of acellular scaffolds to inform future experimental groups. 
Finally, we aim to use observations herein to develop further hypotheses 
relating to tracheal bioengineering and optimization of a future therapeutic 
product.  
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METHODS 
Animals 
Syngeneic male New Zealand White (NZW) rabbits (weights 2.0-2.5 kg) were 
used with certified negative status for Pasteurella and other common 
respiratory pathogens. Rabbits were singly housed with non-particulate 
bedding and environmental stimulation. Animals were fed a normal hay diet 
and were pre-operatively assessed for alertness, cardiorespiratory status and 
weight. Live animal work was ethically approved and carried out under Home 
Office Project Licence PPL70/7504. 
 
Scaffold Manufacture 
Synthetic tracheae were designed and fabricated using nanocomposite 
polymer, Polyhedral Oligomeric Silsesquioxane Poly(carbonate-urea) 
urethane (POSS-PCU), as was used to create a tracheal implant in a single 
reported patient13. Briefly, C-shaped rings of heat-cured POSS-PCU sheets (2 
x 2 x 5 mm) were sutured over silicon mandrels, dip-coated with non-porous 
POSS-PCU and heat-cured to hold them in position. Luminal and external 
surfaces were coated with porous POSS-PCU (interconnected pore sizes of 
40 µm and 105 µm respectively) to allow for blood vessel ingrowth14. Surface 
layers were water-cured with deionized water and the whole structure was 
washed for at least 72 hours to ensure complete solvent removal. 
 
Chemically-preserved tracheal homografts were created using the 
“Herberhold” technique2. Rabbit donor tracheae (n=4) were immersed for 14 
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days in 4% formalin in compound sodium lactate solution, before transfer to 4 
g/L sodium ethylmercurithiosalicylate (thimerosal) in Dulbecco’s phosphate-
buffered saline (PBS; Sigma-Aldrich, UK) solution for 56 days. Homografts 
were stored in acetone until required, with rehydration and thorough washing 
in sterile saline solution prior to use.  
 
NZW rabbit donor tracheae (n=4) were harvested and underwent 
decellularization using a detergent-enzyme protocol15,16. Following washing in 
sterile saline, tracheae were incubated in 0.2% Triton X-100 (Sigma-Aldrich, 
UK) and 0.2% Sodium Deoxycholate (Fluka, Switzerland) in PBS, at 37oC for 
24 hours. After a 48 hour wash in sterile water at 4°C (wash water changed 
three times), tracheae were incubated with 2000 KU (Kunitz Units)/l DNAse 
(Sigma-Aldrich, UK) and 0.1 g/l RNAse (Roche, Switzerland) at 37°C for 24 
hours to solubilize nuclear contents and degrade DNA. After a further 24 
hours of sterile water washing at 4°C, the DNAse/RNAse step was repeated. 
Following decellularization, further intensive washing was performed using 
sterile water over 48 hours. All treatments were carried out under constant 
agitation. Decellularized scaffolds were sterilized by gamma irradiation 
(10,000Gy). 
 
Pre-implantation Analysis 
Biomechanical analysis and scanning electron microscopy was performed on 
batch-matched non-implanted scaffolds from each of the experimental groups 
and compared to freshly retrieved intact 2 cm segments of rabbit trachea 
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(n=3). Biomechanical properties of composite scaffolds (n=4 in each group) 
were analysed using a pneumatic Instron Bluehill 5565 tensile tester (Instron 
Ltd, Bucks, UK)17. Tracheal scaffolds (n=3 for each group) were evaluated for 
tensile strength as a composite structure at longitudinal lengths of 2 cm. 
Constructs were placed within the jaws of the tensile tester and tension was 
steadily increased at 100 mm/min until rupture of the construct. Stress-strain 
curves were generated up to the point of rupture and the structure was 
observed visually to ascertain the location of the tear. Young’s (tensile) 
modulus (YMt), ultimate tensile stress (stress at scaffold failure) and strain at 
failure were compared to tensile strength recordings. The compressive load 
sufficient to cause 25% scaffold occlusion were also measured in 
anteroposterior (A-P) and lateral directions on 2 cm lengths of composite 
scaffolds. A maximum of 25% compression was applied as, with its relatively 
thick wall, the default 50% compression caused the opposing luminal walls of 
the POSS-PCU scaffold to come into contact. The stress applied to cause 
25% compression was then used to calculate the Young’s (compressive) 
modulus (YMc). Sections of scaffold materials were analyzed by scanning 
electron microscopy. Samples were fixed in 2.5% glutaraldehyde, washed in 
0.1M phosphate buffer, dehydrated in a graded ethanol-water series to 100% 
ethanol and critical point dried with carbon dioxide. Samples were sputter-
coated with a 2 nm layer of Gold/Palladium and viewed using a Jeol 7401 
FEG scanning electron microscope (Tokyo, Japan). 
 
Surgical Procedure 
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Anesthesia of recipient animals (n=16) was induced using intramuscular 
injections of Xylazine (6 mg/kg) and Ketamine (40 mg/kg)18 and maintained 
using 1-3% Isoflurane in oxygen via mask delivery. Analgesia (Buprenorphine 
0.05 mg/kg, intramuscular) and antibiotics (Enrofloxacin 0.9 mg/kg, 
subcutaneous) were given at induction. 
 
The cervical trachea was exposed from cricoid ring to suprasternal notch and 
dissected from the esophagus. A 2 - 2.5 cm circumferential cervical tracheal 
segment was excised 4-5 tracheal rings below the cricoid cartilage and 
washed extracorporeally in sterile PBS containing 1X Penicillin/Streptomycin 
(Gibco, UK). Controls (n=4) received reversed autologous segments (aimed 
at reducing the beneficial effect of the mucociliary ladder19). Experimental 
groups received 2 cm lengths of unseeded scaffolds (n=4 each of 
decellularized, POSS-PCU and Herberhold scaffolds). Anastomoses were 
performed at proximal and distal graft ends with 6-0 Polydioxanone suture 
(Supplementary Figure 1).  Animals were allowed to recover gradually on 
discontinuation of Isoflurane delivery.  
 
Post-operative analysis 
Close attention was paid post-operatively for signs of graft obstruction or 
dislodgement, falling oxygen saturations and development of stridor, pain or 
distress20. Analgesia (Buprenorphine 0.05 mg/kg, intramuscular) was given 
regularly for the first 3 postoperative days. Animals received daily antibiotic 
administration (Enrofloxacin 0.9 mg/kg, subcutaneous) throughout the study. 
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All animals underwent weekly bronchoscopic graft monitoring using a 2.9 mm 
0° rigid pediatric bronchoscope (Storz, Germany). Anesthesia was induced 
using the protocol stated above. Developing stenoses were observed and 
recorded dynamically (iPhone app & adaptor; endoscope-i, UK), and areas 
objectively calculated from video stills (ImageJ). No therapeutic 
bronchoscopic interventions were performed. Animals with asymptomatic 
stridor were managed conservatively but animals showing signs of respiratory 
distress (coughing, wheezing, peripheral cyanosis or stridor) underwent 
immediate termination. At 4 weeks, surviving animals underwent 
bronchoscopy under terminal anesthesia, followed by autopsy. Transverse 
sections were taken of the graft (midpoint) and distal native trachea. 
Longitudinal sections were taken across both proximal and distal 
anastomoses. Samples were fixed overnight in 4% paraformaldehyde before 
paraffin embedding, sectioning and staining.. Slides were digitally scanned 
(Nanozoomer Digital Pathology, Hamamatsu Photonics, Japan) at 40x 
magnification for analysis. Epithelialization, granulation tissue formation and 
neovascularization were evaluated using Hematoxylin and Eosin (H&E), 
Masson’s Trichrome (MT), Picosirius Red (PR) and Elastin Van Geeson 
(EVG) stained sections.  
 
Statistical analysis 
Statistical analysis was performed using Prism 6 software (Graphpad, USA). 
Tensile biomechanical measurements were performed on using the unpaired 
Student’s T-test with Welch’s correction for non-equal standard deviations. A-
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P compressive readings were compared using the unpaired Student’s T-test 
with Welch’s correction for non-equal standard deviations. Analysis of lateral 
compressive readings was performed using Wilcoxon matched-pairs signed 
rank test as native tracheal readings did not follow a normal (Gaussian) 
distribution.  
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RESULTS 
Pre-implantation Biomechanical Assessment 
Mean ultimate tensile stress (UTS) was significantly higher for the POSS-PCU 
scaffold than control trachea (3.70 vs 0.55 MPa, p=0.0028) but there were no 
significant differences in UTS between Herberhold, decellularized and control 
groups. There were no significant differences in maximal tensile strains (MTS) 
between groups (p=0.1181). Herberhold scaffolds were more brittle than 
control tracheae, as demonstrated by a lower YMt (1.5 vs 5.8 MPa, p=0.0470) 
but there were no significant differences in YMt between other groups 
(p=0.1292; Figure 2 and Supplementary Figure 2A-D). 
 
POSS scaffolds required significantly higher loads for 50% occlusion in both 
A-P and lateral directions than the other groups (p<0.0001). Herberhold 
tracheae also showed a significantly increased resistance to 50% occlusion 
compared to controls (p=0.0014 (A-P) and p<0.0001 (lateral)). Decellularized 
tracheae showed no significant difference compared to controls (p=0.9859 (A-
P) and 0.7699 (lateral)). 
 
Scanning Electron Microscopy 
POSS-PCU scaffolds had smooth, highly porous luminal surfaces around 
smooth casted struts (Supplementary Figure 2F & J), which appeared to 
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connect to the underlying porous scaffold (Supplementary Figure 2F). 
Herberhold sections demonstrated fixed, preserved donor cells and debris 
both within cartilage lacunae and on surfaces (Supplementary Figure 2G & K). 
Decellularized scaffolds were devoid of cells in both luminal and cartilaginous 
niches and exhibited preservation of surrounding structures (Supplementary 
Figure 2H & L). 
 
Mortality and morbidity 
Semi-quantitative bronchoscopic grading of airway stenoses was adapted 
from the Cotton-Myer Grading System21 (Supplementary Table 1). Three 
trained observers (2 surgeons, 1 material scientist) graded each image 
independently and were blinded as to group (EM/CB/CC). Proximal and distal 
anastomoses were graded separately and the more severe stenosis recorded 
as the overall score. Inter-rater reliability was calculated on a random sample 
of 6 bronchoscopic videos (anastomoses = 10) and found to be %. 
 
All animals survived the first week without respiratory distress or 
laryngospasm and resumed normal appetite, urination and defecation 
patterns within 72 hours. Survival (Supplementary Figure 3), post-mortem 
(Table 1) and bronchoscopic (Table 2) findings diverged significantly from 
week 2. 
  
Control animals survived to termination with mild to moderate stenoses that 
stabilized from week 2. Distal anastomotic mucus accumulation was a 
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common bronchoscopic finding. At post-mortem, bronchoscopic passage to 
the carina was possible in three animals; in the fourth animal of the group, 
circumferential anastomotic granulation prevented scope passage but still 
allowed for a clear view of a patent tracheal lumen from graft to carina. There 
were no visible in-graft stenoses, local inflammatory reactions or fibrous 
encapsulation of grafts. 
 
POSS-PCU and Herberhold groups demonstrated progressive anastomotic 
stenosis with gradual onset of quiet stridor. In the POSS-PCU group, one 
rabbit was terminated on development of sudden onset respiratory distress 
and found to have a mucus plug blocking a severely stenosed distal 
anastomosis. Two rabbits showed a decline in respiratory reserve over 48 
hours and were terminated on day 21. One POSS-PCU rabbit survived to 
termination with minimal respiratory symptoms, but also demonstrated severe 
anastomotic stenoses at post-mortem. POSS-PCU grafts were uniformly 
encapsulated in fibrous tissue with little or no integration into surrounding 
tissues, with concentric anastomotic stenoses from granulation tissue. 
 
In the Herberhold group, one animal died from laryngospasm following its first 
bronchoscopy. Two animals developed pneumonia secondary to retained 
secretions and were terminated on day 19. One animal survived to day 30 
with minimal symptoms, but demonstrated severe proximal anastomotic 
stenosis at post-mortem. Macroscopically, inflammatory exudate was present 
over the external surface of Herberhold grafts, with intense anastomotic 
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granulation tissue. No contact bleeding was evident on the luminal surface of 
these grafts.  
 
Decellularized grafts showed less severe anastomotic granulation than 
POSS-PCU or Herberhold grafts. One rabbit was mildly stridulous from day 5 
and bilateral vocal cord palsies were observed at first bronchoscopy. Graft 
malacia (of both anterior and posterior walls) was seen all animals and all 
required termination due to sudden respiratory distress between days 11 and 
20. No obvious pneumonia, mucus plug or secretion accumulation was seen 
macroscopically at post-mortem. Integration of graft tissue and recipient 
trachea was macroscopically stronger in the decellularized animals than 
POSS-PCU and Herberhold groups.  
 
Macroscopic and Histological features 
Control animals displayed mild degrees of anastomotic granulation tissue 
(Supplementary Figure 4A), and tracheal lumens were patent. No evidence of 
submucosal fibrosis or fibrous encapsulation of the grafted segment was 
seen. Pseudostratified, ciliated, columnar epithelium remained intact 
throughout the length of the reversed autograft (Figure 2A) apart from areas 
of squamous metaplasia directly over healed anastomoses. Erythrocytes were 
present within submucosal capillaries in the grafted segments suggesting 
revascularization or reconnection of submucosal vessels to host vasculature 
(Supplementary Figure 5A). 
 
 16 
In contrast, fibrous encapsulation of POSS-PCU all grafts were observed with 
little or no integration into surrounding tissue (Supplementary Figure 4B). 
There was near-total anastomotic occlusion of tracheal lumens with 
granulation tissue in all four animals but no ingrowth of tissue into the pores of 
the biomaterial or vascularization was seen. The inter-connected pores 
created by the manufacturing method contained frequent basophils, 
eosinophils and cell debris (Supplementary Figure 5B). No blood vessels or 
endothelial cells were identified within pores and no elastin deposits were 
seen within POSS-PCU on Masson’s Trichrome or Elastin Van-Gieson 
staining (data not shown). There were no cells with a respiratory epithelial 
morphology on luminal surfaces (Figure 2B).  
 
Herberhold grafts all exhibited dense inflammatory infiltrates with deposition of 
collagen/fibrosis as shown by Masson’s Trichrome and PicroSirius Red 
staining (data not shown). Profuse granulation tissue occluded the lumen at 
the anastomoses (Supplementary Figure 4C). No blood vessels with lumens 
containing erythrocytes were observed in sections of the graft (Supplementary 
Figure 5C). An incomplete, pseudo-stratified epithelium was observed (Figure 
2C). Frequent eosinophils were seen throughout the epithelium.  
 
Decellularized grafts showed a large expansion in submucosal layer thickness 
with stromal cells and a lymphocytic response, although smaller than that 
seen in POSS-PCU or Herberhold grafts (Supplementary Figure 4D). Unlike 
other groups, there was some evidence of neovascularization or vascular 
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reconnection, as evidenced by small, irregular erythrocyte-filled capillaries in 
the submucosal layer (Supplementary Figure 5D). There was no evidence of 
any development of pseudostratified epithelium at 20 days (the longest 
recorded survival in this group; Figure 2D). 
 
DISCUSSION 
The most effective material for potential use in bioengineered tracheal 
replacement remains unclear22-24. Tracheal interventions are often 
complicated by granulations and stenosis, regardless of the material chosen 
for tracheal reconstruction25-28. Tracheal ‘Herberhold’ homografts have been 
used with moderate success in the clinical setting but do not represent the 
ideal graft due to limited availability, difficulty in procurement and the 
requirement for significant and prolonged post-operative airway intervention. 
These grafts have been principally used for patch augmentation but also to 
replace sections of airway29. A variety of new scaffold materials have 
emerged as potential candidates but to our knowledge they have not been 
directly compared. This study tested two alternate technologies against the 
“standards” of Herberhold homografts and surgical controls in an animal 
setting that could be considered a relevant model for pediatric airway 
transplantation. 
 
Rabbits have comparable anatomy and airway dimensions to human 
neonates and infants30 and are widely accepted as an experimental model for 
tracheal stenosis30,31 and transplantation32-34. In this pilot study, all surgical 
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control animals tolerated a long-segment autograft replacement without any 
airway compromise or distress. Bronchoscopic follow-up demonstrated little 
anastomotic granulation or stenosis and grafts at post mortem appeared to 
retain a ciliated epithelium35. This is a significant observation given that the 
“control” operation completely disconnects the implanted segment of trachea 
from its vascular supply. This rapid reestablishment of a vascular supply is 
likely to support integration35-37 and attenuate granulation formation. However, 
the fact that control autografts were not denuded of epithelium may make 
them a less relevant comparator to unseeded experimental arms30. 
 
Animals in POSS-PCU and Herberhold groups inexorably developed 
occlusive anastomotic granulations and stenosis. The mechanisms that cause 
this anastomotic stenosis may be different in each group. POSS-PCU grafts 
were externally encased in a dense fibrous capsule, and the graft easily 
peeled away at anastomoses from the native tracheal ends implying a lack of 
tissue integration. The inter-connected pores created by the manufacturing 
method contained cell debris but no evidence of neovascularization. 
Inflammatory infiltrates were seen within the submucosal and adventitial 
layers of Herberhold grafts. An epithelial layer was seen, but this likely 
represented the remnants of the chemically fixed donor rather than a living, 
functional neo-epithelium. We hypothesize that the widespread presence of 
eosinophils represents an acute cell-mediated reaction to the fixed, but still 
potentially immunogenic, if not allogeneic, material found in these grafts38,39. 
Both POSS-PCU and Herberhold grafts were significantly ‘stiffer’ than native 
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trachea on compression testing. It has been proposed than mechanical 
mismatch between graft and native tissues can be a negative prognostic 
indicator for graft integration40 and may also contribute to granulation tissue 
formation at the anastomosis. There was no significant difference in maximal 
tensile strains between experimental groups and controls, which would 
indicate a low potential risk of scaffold rupture in therapeutic interventions 
such as endoluminal ballooning of granulations41, at least in the early phase 
before remodeling. We did not have the facility or equipment capability to 
manage stenosis and granulations endoscopically during this pilot study, but 
addition of these capabilities will enable us to more closely model the clinical 
scenario in future experimental groups, facilitating rabbit survival and enabling 
evaluation of graft integration over longer periods42. 
 
In contrast, decellularized grafts became overtly malacic by the second week 
post-implantation, implying a degree of remodeling in vivo. Some animals in 
this group exhibited sudden deteriorations in respiratory function akin to ‘dying 
spells’, a clinical hallmark of severe pediatric tracheobronchomalacia43. The 
mechanisms underlying the cellular response to decellularized scaffolds are 
less clear but may represent a reaction to epitopes or growth factors retained 
in the scaffold, retained decellularization agent contamination or a remodeling 
process of the exposed extracellular matrix. Less aggressive tracheal 
decellularization methods, such as cryopreservation with epithelium 
denudation44, might better preserve graft structure and function but this may 
be at the expense of increasing immunogenicity, something that will need to 
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be assessed experimentally. The contribution of gamma irradiation 
sterilization to the malacia of tracheal grafts is unknown. Gamma irradiation 
has been shown to increase resistance and elastance in decellularised mouse 
lung, albeit at much higher doses than those employed in this study45. 
Temporary intraluminal stenting of decellularized scaffolds might address the 
problem of malacia during remodeling46. 
 
Stenosis may be exacerbated by poor graft neovascularization which could be 
in part due to the lack of cues to encourage ingrowth47 and seeding scaffolds 
with cells may lead to significant advantages in this regard as well as in 
functional epithelium establishment30. Indeed, the addition of autologous 
mesenchymal stem cells to decellularized scaffolds has been shown in a pilot 
study of a similar rabbit model to alter the host response and improve 
outcomes in terms of regeneration and function33. Further experimental arms 
are planned to test combinations of epithelial and/or mesenchymal stem cell 
graft seeding48 to evaluate the fate of these transplanted cells, their effect on 
graft granulation and stenosis and their potential contribution towards tracheal 
regeneration. 
 
CONCLUSION 
Significant developments have been made in the field of conventional 
transplantation but for allogeneic tracheal transplants appropriately sized 
donors are scarce and anti-rejection drugs are potentially harmful. In this pilot 
study we examined multiple scaffold materials that have been employed 
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clinically. Although in a small number of animals, neither decellularized nor 
synthetic scaffolds emerged as a preferred option over  ‘gold standard’ 
chemically preserved tracheal homografts. Further work is required to identify 
whether either strategy shows further clinical promise. Work to optimize the 
integration, vascularization and epithelialization of the candidate(s) should be 
performed. Experiments with cell-seeded grafts will be essential and will 
better mimic the use of such scaffolds in compassionate clinical cases than 
the simplified approach taken here. These may elucidate a clearer advantage 
of one scaffold material over another in the search for a universally effective 
means of tracheal replacement in children and adults. 
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FIGURE LEGENDS  
Figure 1: Biomechanical preimplantation analysis of grafts: comparisons of 
ultimate tensile strain (A) and anterior-posterior compressive load at 50% 
occlusion (B).  
 
Figure 2: Haematoxylin & Eosin (H&E) staining of luminal surface at mid-
point of graft. Scale bar = 100 µm. (A) Control – largely intact layer of 
pseudostratified respiratory epithelium. (B) POSS-PCU – No respiratory 
epithelium seen, eosinophil migration throughout graft (arrow). (C) Herberhold 
– fixed donor epithelium seen with copious lymphocytic infiltrate. (D) 
Decellularized grafts – Fibroblastic expansion of luminal surface without 
respiratory epithelium. 
 
Table 1: Summary of bronchoscopic findings. 
Table 2: Representative bronchoscopic findings. 
 
SUPPLEMENTARY FIGURE LEGENDS  
 
Supplementary Figure 1: Representative intraoperative photographs of end-
to-end anastomosis of (A) control, (B) POSS-PCU, (C) Herberhold and (D) 
Decellularized grafts. 
 
 23 
Supplementary Figure 2: Pre-implantation analysis of grafts. Biomechanical 
testing: comparisons of ultimate tensile stress (A); ultimate tensile strain (B); 
anterior-posterior (C) and lateral (D) compressive load at 50% occlusion. 
Scanning electron microscopy of scaffolds: Transverse sections x 200 
magnification: (E) Control rabbit trachea; (F) POSS-PCU scaffold; (G) 
Herberhold and (H) Decellularized grafts. Luminal surfaces x 1000 
magnification: (I) Control rabbit trachea; (J) POSS-PCU scaffold; (K) 
Herberhold and (L) Decellularized grafts. 
 
Supplementary Figure 3: Kaplan-Meier survival curves to experiment 
termination at four weeks. 
 
Supplementary Figure 4: Haematoxylin & Eosin (H&E) staining of 
longitudinal sections through anastomoses. Scale bar = 500 µm. (A) Control - 
minimal anastomotic granulation (*). (B) POSS-PCU – lack of scaffold (S) 
integration with intense overgrowth of granulation tissue (*). (C) Herberhold – 
intense anastomotic granulation tissue (G) with lymphocytic infiltrate (#) 
throughout graft. (D) Decellularized grafts – large submucosal expansion with 
stromal cells and mucus-filled lumen (M). 
 
Supplementary Figure 5: Haematoxylin & Eosin (H&E) staining of 
submucosal layer at mid-point of graft. Scale bar 500 µm. (A) Control – intact 
submucosal vasculature. 
 24 
(B) POSS-PCU – pores containing copious cell debris but no discernable 
vessels. (C) Herberhold – intact submucosal vasculature with red blood cells 
within lumen. (D) Decellularized grafts – copious granulation tissue and 
irregular neovascularization with expansion of submucosal layer, suggesting 
in-stent stenosis. 

Supplementary Table 1: Adaptation of the Cotton-Myer grading system for 
subglottic stenosis. 
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Figure 1: Biomechanical preimplantation analysis of grafts: comparisons of ultimate
tensile strain (A) and anterior-posterior compressive load at 50% occlusion (B).
Animal Week 1 Week 2 Week 3 Week 4 (Terminal) Survival in Days
(Cause of Death)
Control (Autograft)
1 - Grade 0 (both ends) - Grade 0 (proximal)
- Grade I (distal) - granulation tissue at posterior 
distal suture line
- Contact bleeding
- Grade 0 (proximal)
- Grade II (distal) - progression of exophytic 
granulation tissue
- Grade II (distal) – focal granulation tissue as 
before
32
(End of experiment)
2 - Grade 0 (both ends) - Grade 0 (both ends)
- Mucus overlying distal anastomosis (easily cleared)
- Grade I (both ends) - Grade I (both ends) - able to pass scope to 
carina
32
(End of experiment)
3 - Grade 0 (both ends) - Grade I (proximal)
- Grade 0 (distal)
- Mucus overlying anastomoses distal > proximal
- Grade 0 (distal) - Grade 0 (distal) 30
(End of experiment)
4 - Grade 0 (both ends) - Grade 0 (both ends) - Grade I (both ends) - Grade I (both ends) 30
(End of experiment)
POSS-PCU (Synthetic Nanocomposite Polymer Graft)
5 - Grade 0 (distal) - Grade I (proximal) - eccentric stenosis posterior > 
anterior
- Grade 0 (distal)
- Grade IV (distal) - ‘pinhole’ stenosis - Loose secretions. 30
(End of experiment)
6 - Grade 0 (both ends) - Grade I (distal) – just able to pass scope - Grade II (proximal)
- Grade IV (distal) - ‘pinhole’ stenosis
- 21
(Termination - anastomotic stenosis)
7 - Grade 0 (both ends) - Procedure abandoned (anaesthesia induction 
failure & mild laryngospasm on trial of gas 
anaesthetic)
- Grade IV (distal) ‘pinhole’ - 21
(Termination - anastomotic stenosis)
8 - Grade I (distal) - contact bleeding - Copious loose secretions - Mucus obliterating central graft lumen - 19
(Mucus plugging on background of stenosis)
Herberhold (Preserved Rabbit Trachea)
9 - Grade 0 (both ends) - Grade I (proximal)
- Grade 0 (distal)
- Grade II (both ends) - Grade IV (proximal)
- Grade II (distal)
30
(End of experiment)
10 - Grade 0 (both ends) - Grade 0 (proximal)
- Grade III (distal)
- Grade II (proximal)*
- Grade III (distal)
- 19
(Termination - pneumonia from retained 
secretions)
11 - Grade 0 (both ends) - Grade II (both ends) - Grade III (proximal)*
- Grade II (distal)
- 19
(Termination - pneumonia from retained 
secretions)
12 - Grade 0 (both ends) - - - 7
(Laryngospasm on anaesthesia reversal)
Decellularized Rabbit Trachea
13 - Grade 0 (both ends)
- In-drawing of trachealis into graft 
lumen
- Grade II (proximal)
- Grade I (distal)
- In-drawing of trachealis into graft lumen
- - 20 (Mucus plugging on background of malacia)
14 - Bilateral vocal cord palsies
- Grade 0 (both ends)
- Bilateral vocal cord palsies - Grade 0 (proximal)
- Grade I (distal)
- Significant graft malacia
- - 16 (Termination – respiratory distress from 
malacia on background of VC palsies)
15 - Grade 0 (both ends)
- In-drawing of trachealis into graft 
lumen
- Grade 0 (both ends)
- Severe graft malacia* (collapse of both anterior and 
posterior graft walls into lumen on inspiration)
- - 15 (Termination – respiratory distress from 
malacia)
16 - Grade 0 (both ends)
- In-drawing of trachealis into graft 
lumen
- - - 11 (Termination – respiratory distress from 
malacia)
Table 1: Summary of bronchoscopic findings. Grading refers to degree of anastomotic stenosis (see Supplementary Table 1)

Figure 2: Haematoxylin & Eosin stain of luminal surface at mid-point of graft - scale bar 100µm.
(A) Control – largely intact layer of pseudostratified respiratory epithelium. (B) POSS-PCU – No respiratory
epithelium seen, eosinophil migration throughout graft (arrow). (C) Herberhold – fixed donor epithelium seen with
copious lymphocytic infiltrate. (D) Decellularized – Fibroblastic expansion of luminal surface without respiratory
epithelium.
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Supplementary Figure 1: Representative intraoperative photographs of end-to-end anastomosis
of (A) control, (B) POSS-PCU, (C) Herberhold and (D) Decellularized grafts.
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Supplementary Figure 2: Preimplantation analysis of grafts.
Biomechanical Testing: comparisons of ultimate tensile stress (A); ultimate tensile strain (B); anterior-posterior
(C) and lateral (D) compressive load at 50% occlusion.
Scanning electron microscopy of scaffolds. Transverse sections x 200 magnification: (E) Control rabbit
trachea; (F) POSS-PCU scaffold; (G) Herberhold and (H) Decellularized grafts. Luminal surfaces x 1000
magnification: (I) Control rabbit trachea; (J) POSS-PCU scaffold; (K) Herberhold and (L) Decellularized grafts.
Supplementary Figure 3: Kaplan-Meier survival curves to experiment termination at 30 days. 
BDC
Supplementary Figure 4: Haematoxylin & Eosin stain of longitudinal sections through anastomoses -
scale bar 500µm.
(A) Control - minimal anastomotic granulation (*). (B) POSS-PCU – lack of scaffold (S) integration with 
florid overgrowth of granulation tissue (*). (C) Herberhold – florid anastomotic granulation tissue (G) with 
lymphocytic infiltrate (#) throughout graft. (D) Decellularized – large submucosal expansion with fibroblast-
like cells with mucus-filled lumen (M).
S
*
#
A
*
M
Supplementary Figure 5: Haematoxylin & Eosin (H&E) staining of submucosal layer at mid-point of graft. Scale bar
500 µm. (A) Control – intact submucosal vasculature. (B) POSS-PCU – pores containing copious cell debris but no
discernable vessels. (C) Herberhold – intact submucosal vasculature with red blood cells within lumen. (D)
Decellularized grafts – copious granulation tissue and irregular neovascularization with expansion of submucosal
layer, suggesting in-stent stenosis.

